Effect of anemia on cardiac disorders in pre-dialysis patients immediately before starting hemodialysis

Clinical and Experimental Nephrology

Volumn 15, Issue 1, 2011, Pages 121-125

  Kuwahara, Michio ^a   Iimori, Soichiro ^a   Kuyama, Tamaki ^a   Akita, Wataru ^a   Mori, Yoshihiro ^a   Asai, Tomoki ^a   Tsukamoto, Yusuke ^a   Adachi, Susumu ^a   Rai, Tatemitsu ^b   Uchida, Shinichi ^b   Sasaki, Sei ^b  

^a Shuwa General Hospital   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Echocardiography; Erythropoietin

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; EARLY DIASTOLIC WAVE DECELERATION TIME; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODYNAMIC PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTERIOR WALL THICKNESS;

AGED; ANEMIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 79952190590     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-010-0360-6     Document Type: Article

References (22)

1. A Levin CR Thompson J Ethier EJ Carlisle S Tobe D Mendelssohn, et al. 1999 Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 125 134 1:STN:280:DyaK1MzjtV2hsg%3D%3D 10.1016/S0272-6386(99)70118-6 10401026 (Pubitemid 29318806)
2. CY Hsu DW Bates GJ Kuperman GC Curhan 2001 Relationship between hematocrit and renal function in men and women Kidney Int 59 725 731 1:CAS:528:DC%2BD3MXhtlKitLs%3D 10.1046/j.1523-1755.2001.059002725.x 11168955 (Pubitemid 32157938)
3. BC Astor P Muntner A Levin JA Eustace J Coresh 2002 Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 1401 1408 10.1001/archinte.162.12.1401 12076240 (Pubitemid 34655201)
4. A Al-Ahmad WM Rand G Manjunath MA Konstam DN Salem AS Levey, et al. 2001 Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction J Am Coll Cardiol 38 955 962 1:STN:280:DC%2BD3Mrjs1Wlug%3D%3D 10.1016/S0735-1097(01)01470-X 11583864 (Pubitemid 32912694)
5. MJ Sarnak H Tighiouart G Manjunath B MacLeod J Griffith D Salem, et al. 2002 Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study J Am Coll Cardiol 40 27 33 10.1016/S0735- 1097(02)01938-1 12103252 (Pubitemid 34701373)
6. PC Lee AS Kini C Ahsan E Fisher SK Sharma 2004 Anemia is an independent predictor of mortality after percutaneous coronary intervention J Am Coll Cardiol 44 541 546 10.1016/j.jacc.2004.04.047 15358017 (Pubitemid 39078176)
7. D Roth RD Smith G Schulman TI Steinman FE Hatch MR Rudnick, et al. 1994 Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients Am J Kidney Dis 24 777 784 1:STN:280: DyaK2M%2Fmsl2hsw%3D%3D 7977319 (Pubitemid 24350464)
8. S Kuriyama H Tomonari H Yoshida T Hashimoto Y Kawaguchi O Sakai 1997 Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients Nephron 77 176 185 1:CAS:528:DyaK2sXmslSqurc%3D 10.1159/000190270 9346384 (Pubitemid 27440408)
9. P Jungers G Choukroun Z Oualim C Robino AT Nguyen NK Man 2001 Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients Nephrol Dial Transpl 16 307 312 1:CAS:528:DC%2BD3MXhtlKnt7w%3D 10.1093/ndt/16.2.307 (Pubitemid 32123919)
10. PA McKee WP Castelli PM McNamara WB Kannel 1971 The natural history of congestive heart failure: the Framingham study N Engl J Med 285 1441 1446 1:STN:280:DyaE38%2FkvFGmtA%3D%3D 10.1056/NEJM197112232852601 5122894
11. RB Devereux N Reichek 1977 Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method Circulation 55 613 618 1:STN:280:DyaE2s7hsVClsQ%3D%3D 138494 (Pubitemid 8066109)
12. MM Redfield SJ Jacobsen JC Jr Burnett DW Mahoney KR Bailey RJ Rodeheffer 2003 Burden of systolic and diastolic ventricular dysfunction in the community Am J Med Assoc 289 194 202 10.1001/jama.289.2.194 (Pubitemid 36068707)
13. S Nakai I Masakane T Shigematsu T Hamano K Yamagata Y Watanabe, et al. 2009 An overview of regular dialysis treatment in Japan (as of 31 December 2007) Ther Apher Dial 13 457 504 10.1111/j.1744-9987.2009.00789.x 19954472
14. RN Foley PS Parfrey JD Harnett GM Kent DC Murray PE Barre 1995 The prognostic importance of left ventricular geometry in uremic cardiomyopathy J Am Soc Nephrol 5 2024 2031 1:STN:280:DyaK28%2Fntlajuw%3D%3D 7579050
15. PS Parfrey RN Foley JD Harnett GM Kent DC Murray PE Barre 1996 The outcome and risk factors for left ventricular disorders in chronic uremia Nephrol Dial Transpl 11 1277 1285 1:STN:280:DyaK28zisFentg%3D%3D (Pubitemid 26241416)
16. T Hayashi A Suzuki T Shoji M Togawa N Okada Y Tsubakihara, et al. 2000 Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure Am J Kidney Dis 35 250 256 1:CAS:528:DC%2BD3cXhtFSitbY%3D 10.1016/S0272-6386(00)70334-9 10676724 (Pubitemid 30070847)
17. DS Silverberg D Wexler M Blum G Keren D Sheps E Leibovitch, et al. 2000 The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations J Am Coll Cardiol 35 1737 1744 1:CAS:528:DC%2BD3cXktlGlt7Y%3D 10.1016/S0735-1097(00)00613-6 10841219 (Pubitemid 30342851)
18. DS Silverberg D Wexler M Blum JZ Tchebiner D Sheps G Keren, et al. 2003 The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron Nephrol Dial Transpl 18 141 146 1:CAS:528:DC%2BD38XpsFOntbk%3D 10.1093/ndt/18.1.141 (Pubitemid 36104490)
19. RN Foley PS Parfrey J Morgan PE Barre P Campbell P Cartier, et al. 2000 Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy Kidney Int 58 1325 1335 1:CAS:528:DC%2BD3cXmslehtbg%3D 10.1046/j.1523-1755.2000.00289.x 10972697
20. H Frank K Heusser B Höffken P Huber RE Schmieder Schobel, et al. 2004 Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients Kidney Int 66 832 840 1:CAS:528:DC%2BD2cXmvVegtrk%3D 10.1111/j.1523-1755.2004.00810.x 15253740 (Pubitemid 38982028)
21. A Kirkpantur S Kahraman R Yilmaz M Arici B Altun Y Erdem, et al. 2005 The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters Artif Organs 29 965 972 10.1111/j.1525-1594.2005. 00166.x 16305652 (Pubitemid 43943032)
22. PS Parfrey RN Foley 1999 The clinical epidemiology of cardiac disease in chronic renal failure J Am Soc Nephrol 10 1606 1615 1:STN:280: DyaK1Mzjt1Whuw%3D%3D 10405218 (Pubitemid 29297538)